|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 207,000.00 KRW | +5.45% |
|
+15.00% | +47.44% |
| 08/02 | Vect-Horus Reports CNS-Focused Research Collaboration with OliX Pharmaceuticals | CI |
| 02/12 | Olix Pharmaceuticals receives milestone payment from L'Oréal | RE |
| Capitalization | 4,179B 2.81B 2.43B 2.19B 2.1B 3.83B 259B 4.01B 25.89B 10.37B 124B 10.56B 10.34B 444B | P/E ratio 2025 * |
-103x | P/E ratio 2026 * | 390x |
|---|---|---|---|---|---|
| Enterprise value | 4,179B 2.81B 2.43B 2.19B 2.1B 3.83B 259B 4.01B 25.89B 10.37B 124B 10.56B 10.34B 444B | EV / Sales 2025 |
193x | EV / Sales 2026 * | 99.5x |
| Free-Float |
69.75% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | +5.45% | ||
| 1 week | +15.00% | ||
| Current month | +15.00% | ||
| 1 month | +69.12% | ||
| 3 months | +73.08% | ||
| 6 months | +133.37% | ||
| Current year | +47.44% |
| 1 week | 162,900 |  | 217,000 |
| 1 month | 122,900 | | 217,000 |
| Current year | 111,800 | | 217,000 |
| 1 year | 34,500 | | 217,000 |
| 3 years | 8,280 | | 217,000 |
| 5 years | 8,280 | | 217,000 |
| 10 years | 8,280 | | 217,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dong-Gi Lee
CEO | Chief Executive Officer | 54 | 01/02/2010 |
Young-Jin Kim
DFI | Director of Finance/CFO | 40 | - |
Young-Hye Baek
PRN | Corporate Officer/Principal | 51 | 28/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Sin-Young Park
BRD | Director/Board Member | 61 | 19/03/2019 |
Chung-Gil Kang
BRD | Director/Board Member | 55 | 19/03/2019 |
Dong-Gi Lee
CHM | Chairman | 54 | 01/02/2010 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.45% | +15.00% | +329.02% | +803.93% | 2.81B | |
| -0.61% | -5.35% | +12.03% | +92.93% | 44.16B | |
| +0.92% | -4.81% | +49.26% | +14.90% | 40.5B | |
| -2.40% | -6.16% | +87.11% | +608.08% | 30.21B | |
| -0.44% | -7.92% | -6.69% | -21.33% | 25.47B | |
| +2.54% | -9.65% | +53.01% | -34.70% | 19.22B | |
| -2.62% | -6.49% | +4.16% | -31.60% | 16.5B | |
| +5.20% | +0.37% | +47.19% | +154.57% | 12.64B | |
| +1.14% | -8.92% | -15.02% | +994.93% | 11.72B | |
| +4.43% | -0.31% | +55.98% | - | 11.51B | |
| Average | +1.36% | -3.07% | +61.60% | +286.86% | 21.47B | |
| Weighted average by Cap. | +0.36% | -4.90% | +37.56% | +183.12% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 7B 4.71M 4.06M 3.67M 3.52M 6.42M 433M 6.72M 43.37M 17.37M 208M 17.69M 17.31M 743M | 42B 28.28M 24.38M 22.01M 21.12M 38.51M 2.6B 40.31M 260M 104M 1.25B 106M 104M 4.46B |
| Net income | -39B -26.26M -22.64M -20.44M -19.61M -35.76M -2.41B -37.43M -242M -96.8M -1.16B -98.56M -96.46M -4.14B | 11B 7.41M 6.39M 5.76M 5.53M 10.09M 681M 10.56M 68.15M 27.3M 326M 27.8M 27.21M 1.17B |
| Net Debt | - | - |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 207,000.00 ₩ | +5.45% | 418,439 |
| 05/03/26 | 196,300.00 ₩ | +20.13% | 702,012 |
| 04/03/26 | 163,400.00 ₩ | -15.86% | 684,305 |
| 03/03/26 | 194,200.00 ₩ | +7.89% | 871,904 |
| 27/02/26 | 180,000.00 ₩ | +12.92% | 802,519 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
207,000.00KRW
Average target price
160,000.00KRW
Spread / Average Target
-22.71%
Annual profits - Rate of surprise
- Stock Market
- Equities
- A226950 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition